VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 38 filers reported holding VERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,183 | -14.6% | 16,060 | 0.0% | 0.28% | -23.1% |
| Q2 2023 | $257,763 | +106.8% | 16,060 | 0.0% | 0.36% | +337.3% |
| Q1 2023 | $124,626 | -59.9% | 16,060 | 0.0% | 0.08% | -51.2% |
| Q4 2022 | $310,761 | -9.1% | 16,060 | 0.0% | 0.17% | -11.0% |
| Q3 2022 | $342,000 | +56.2% | 16,060 | 0.0% | 0.19% | +73.6% |
| Q2 2022 | $219,000 | -41.9% | 16,060 | 0.0% | 0.11% | -30.4% |
| Q1 2022 | $377,000 | -56.1% | 16,060 | -50.0% | 0.16% | -53.9% |
| Q4 2021 | $858,000 | – | 32,120 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |